Bietti’s Crystalline Dystrophy is a rare, slowly progressive retinal condition named for a distinctive feature seen on eye examination: small, glistening yellow-white crystalline deposits scattered across the retina. It is reported more frequently in East Asian populations but occurs worldwide, and Somali patients referred with this diagnosis are usually identified after a local ophthalmologist notices the characteristic crystalline appearance during a routine fundus exam.
Because the crystals themselves are a visible marker rather than the direct cause of vision loss, evaluation focuses on how much of the surrounding retinal tissue has already been affected by the underlying degenerative process, which is what ultimately determines visual function.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Because progression is typically slow, care planning for Bietti’s Crystalline Dystrophy centres on regular monitoring to track the rate of change, with regenerative stem cell therapy considered for eligible patients as a supportive measure aimed at preserving the retinal tissue that remains functionally intact.
“The crystals are more of a diagnostic marker than a direct threat — it is the accompanying thinning of the retina and choroid around them that drives the actual decline in vision, and that is what evaluation and monitoring focus on.”
”
It tends to progress slowly, often over many years to decades, though the rate varies between individuals. This is part of why periodic monitoring, rather than a single evaluation, is generally recommended.”
“It has been reported more frequently in East Asian populations in published literature, though it is not confined to any single ethnicity and does occur elsewhere, including in patients of Somali and broader East African background.”
“The presence of the distinctive crystalline deposits on fundus examination, combined with confirmation of a CYP4V2 mutation on genetic testing, is what distinguishes Bietti’s Crystalline Dystrophy from other rod-cone dystrophies that can otherwise look similar in their symptom pattern.”
